Effects of non-invasive ventilation in subjects undergoing cardiac surgery on length of hospital stay and cardiac-pulmonary complications: a systematic review and meta-analysis.

Cardiac surgical procedure continuous positive airway pressure (CPAP) length of stay noninvasive ventilations postoperative complications pulmonary atelectasis

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
Apr 2020
Historique:
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 13 5 2020
Statut: ppublish

Résumé

Cardiac surgery often leads to pulmonary complications. Non-invasive ventilation (NIV) is a mechanical ventilation modality that may help to prevent the pulmonary complications, and the role of the prophylactic use of NIV in patients after cardiac surgery remains controversial. We searched PubMed, Embase, Web of Science and Cochrane Central for randomized controlled trials comparing the use of NIV (continues positive airway pressure or bi-level positive airway pressure) with standard treatment in post-cardiac surgery subjects without language restriction. Two investigators screened the eligible studies up to July, 2019. Meta-analysis using random effect model or fixed effect model was conducted for pulmonary complications, mortality, rate of reintubation and cardiac complications, and mean difference (MD) or standard mean difference for length of hospital stay and length of ICU stay. We included nine randomized controlled trails with 830 subjects. The use of NIV failed to reduce the risk of pulmonary complications, including atelectasis [risk rate (RR) 0.60; 95% confidence interval (CI): 0.28 to 1.28, P=0.19] and pneumonia (RR 0.27; 95% CI: 0.05 to 1.64, P=0.16). However, it has shortened the length of ICU stay (MD -1.00 h, 95% CI: -1.38 to -0.63, P<0.00001) and the length of hospital stay (MD -1.00 d, 95% CI: -1.12 to -0.87, P<0.00001). NIV also failed to reduce the rate of reintubation (RR 0.68; 95% CI: 0.21 to 2.26, P=0.53) or the risk of cardiac complications (RR 0.81; 95% CI: 0.59 to 1.13, P=0.22). The prophylactic use of NIV immediately in post-cardiac subjects who underwent cardiac surgery might be able to shorten the length of hospital stay and the length of ICU stay, but it has no significant effect on pulmonary complications, rate of reintubation or cardiac complications.

Sections du résumé

BACKGROUND BACKGROUND
Cardiac surgery often leads to pulmonary complications. Non-invasive ventilation (NIV) is a mechanical ventilation modality that may help to prevent the pulmonary complications, and the role of the prophylactic use of NIV in patients after cardiac surgery remains controversial.
METHODS METHODS
We searched PubMed, Embase, Web of Science and Cochrane Central for randomized controlled trials comparing the use of NIV (continues positive airway pressure or bi-level positive airway pressure) with standard treatment in post-cardiac surgery subjects without language restriction. Two investigators screened the eligible studies up to July, 2019. Meta-analysis using random effect model or fixed effect model was conducted for pulmonary complications, mortality, rate of reintubation and cardiac complications, and mean difference (MD) or standard mean difference for length of hospital stay and length of ICU stay.
RESULTS RESULTS
We included nine randomized controlled trails with 830 subjects. The use of NIV failed to reduce the risk of pulmonary complications, including atelectasis [risk rate (RR) 0.60; 95% confidence interval (CI): 0.28 to 1.28, P=0.19] and pneumonia (RR 0.27; 95% CI: 0.05 to 1.64, P=0.16). However, it has shortened the length of ICU stay (MD -1.00 h, 95% CI: -1.38 to -0.63, P<0.00001) and the length of hospital stay (MD -1.00 d, 95% CI: -1.12 to -0.87, P<0.00001). NIV also failed to reduce the rate of reintubation (RR 0.68; 95% CI: 0.21 to 2.26, P=0.53) or the risk of cardiac complications (RR 0.81; 95% CI: 0.59 to 1.13, P=0.22).
CONCLUSIONS CONCLUSIONS
The prophylactic use of NIV immediately in post-cardiac subjects who underwent cardiac surgery might be able to shorten the length of hospital stay and the length of ICU stay, but it has no significant effect on pulmonary complications, rate of reintubation or cardiac complications.

Identifiants

pubmed: 32395288
doi: 10.21037/jtd.2020.02.30
pii: jtd-12-04-1507
pmc: PMC7212120
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1507-1519

Informations de copyright

2020 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd.2020.02.30). The authors have no conflicts of interest to declare.

Références

Am J Respir Crit Care Med. 1997 Feb;155(2):500-5
pubmed: 9032185
Eur J Cardiothorac Surg. 1990;4(3):156-61; discussion 161-2
pubmed: 2334554
Rev Bras Cir Cardiovasc. 2011 Oct-Dec;26(4):582-90
pubmed: 22358273
Am J Cardiol. 1990 Feb 1;65(5):309-13
pubmed: 2105627
Rev Bras Ter Intensiva. 2010 Dec;22(4):363-8
pubmed: 25302513
Chest. 2009 May;135(5):1252-1259
pubmed: 19017864
Braz J Cardiovasc Surg. 2017 Jul-Aug;32(4):301-311
pubmed: 28977203
Intensive Care Med. 2011 Jun;37(6):918-29
pubmed: 21424246
Clinics (Sao Paulo). 2008 Apr;63(2):201-6
pubmed: 18438574
Acta Anaesthesiol Scand. 1994 May;38(4):311-6
pubmed: 8067215
Chest. 1987 Oct;92(4):621-4
pubmed: 3308344
Crit Care Med. 1990 Aug;18(8):836-40
pubmed: 2199148
J Cardiothorac Vasc Anesth. 2012 Oct;26(5):917-22
pubmed: 21835640
Intensive Care Med. 1998 Oct;24(10):1113-4
pubmed: 9840250
Surg Gynecol Obstet. 1990 Oct;171(4):299-304
pubmed: 2218834
Clinics (Sao Paulo). 2017 Oct;72(10):618-623
pubmed: 29160424
Acta Anaesthesiol Scand. 2002 Aug;46(7):860-5
pubmed: 12139543
Cochrane Database Syst Rev. 2015 Sep 25;(9):CD010355
pubmed: 26407182
Anesthesiology. 2000 May;92(5):1467-72
pubmed: 10781293
Acta Anaesthesiol Scand. 2000 Jan;44(1):75-81
pubmed: 10669276
Chest. 1985 Feb;87(2):151-7
pubmed: 3881226
Glob J Health Sci. 2015 Mar 26;7(7 Spec No):97-105
pubmed: 26153209
Rev Bras Cir Cardiovasc. 2008 Jul-Sep;23(3):344-50
pubmed: 19082322
Lancet. 2015 Apr 27;385 Suppl 2:S11
pubmed: 26313057
J Thorac Cardiovasc Surg. 2013 Oct;146(4):912-8
pubmed: 23582830
Saudi Med J. 2012 Nov;33(11):1190-5
pubmed: 23147875

Auteurs

Qinhan Wu (Q)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Guiling Xiang (G)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Jieqiong Song (J)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Liang Xie (L)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Xu Wu (X)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Shengyu Hao (S)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Xiaodan Wu (X)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Zilong Liu (Z)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Shanqun Li (S)

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Classifications MeSH